SEARCH

SEARCH BY CITATION

References

  • Anderson DH, Talaga KC, Rivest AJ, Barron E, Hageman GS, Johnson LV (2004) Characterization of beta amyloid assemblies in drusen: the deposits associated with aging and age-related macular degeneration. Exp Eye Res 78: 243- 256
  • Bjorklund C, Oscarson S, Benkestock K, Borkakoti N, Jansson K, Lindberg J, Vrang L, Hallberg A, Rosenquist A, Samuelsson B (2010) Design and synthesis of potent and selective BACE-1 inhibitors. J Med Chem 53: 1458- 1464
  • Boulton M, McKechnie NM, Breda J, Bayly M, Marshall J (1989) The formation of autofluorescent granules in cultured human RPE. Invest Ophthalmol Vis Sci 30: 82- 89
  • Boulton ME, Cai J, Grant MB, Zhang Y (2008a) Gamma-secretase regulates VEGFR-1 signalling in vascular endothelium and RPE. Adv Exp Med Biol 613: 313- 319
  • Boulton ME, Cai J, Grant MB (2008b) γ-Secretase: a multifaceted regulator of angiogenesis. J Cell Mol Med 12: 781- 795
  • Brunner S, Skosyrski S, Kirschner-Schwabe R, Knobeloch KP, Neidhardt J, Feil S, Glaus E, Luhmann UF, Ruther K, Berger W et al (2010) Cone versus rod disease in a mutant Rpgr mouse caused by different genetic backgrounds. Invest Ophthalmol Vis Sci 51: 1106- 1115
  • Caballero S, Swaney J, Moreno K, Afzal A, Kielczewski J, Stoller G, Cavalli A, Garland W, Hansen G, Sabbadini R et al (2009) Anti-sphingosine-1-phosphate monoclonal antibodies inhibit angiogenesis and sub-retinal fibrosis in a murine model of laser-induced choroidal neovascularization. Exp Eye Res 88: 367- 377
  • Cai J, Jiang WG, Grant MB, Boulton ME (2006) Pigment epithelium-derived factor inhibits angiogenesis via regulated intracellular proteolysis of vascular endothelial growth factor receptor 1. J Biol Chem 281: 3604- 3613
  • Cai J, Wu L, Qi X, Li Calzi S, Caballero S, Shaw L, Ruan Q, Grant MB, Boulton ME (2011a) PEDF regulates vascular permeability by a gamma-secretase-mediated pathway. PLoS One 6: e21164
  • Cai J, Chen Z, Ruan Q, Han S, Liu L, Qi X, Boye SL, Hauswirth WW, Grant MB, Boulton ME (2011b) Gamma-secretase and presenilin mediate cleavage and phosphorylation of vascular endothelial growth factor receptor-1. J Biol Chem 286: 42514- 42523
  • Cai J, Wu L, Qi X, Shaw L, Li Calzi S, Caballero S, Jiang WG, Vinores SA, Antonetti D, Ahmed A, et al (2011c) Placenta growth factor-1 exerts time-dependent stabilization of adherens junctions following VEGF-induced vascular permeability. PLoS One 6: e18076
  • De Strooper B, Vassar R, Golde T (2010) The secretases: enzymes with therapeutic potential in Alzheimer disease. Nat Rev Neurol 6: 99- 107
  • Ding JD, Johnson LV, Herrmann R, Farsiu S, Smith SG, Groelle M, Mace BE, Sullivan P, Jamison JA, Kelly U et al (2011) Anti-amyloid therapy protects against retinal pigmented epithelium damage and vision loss in a model of age-related macular degeneration. Proc Natl Acad Sci USA 108: E279- E287
  • Dominguez D, Tournoy J, Hartmann D, Huth T, Cryns K, Deforce S, Serneels L, Camacho IE, Marjaux E, Craessaerts K et al (2005) Phenotypic and biochemical analyses of BACE1-and BACE2-deficient mice. J Biol Chem 280: 30797- 30806
  • Jarrett SG, Boulton ME (2005) Antioxidant up-regulation and increased nuclear DNA protection play key roles in adaptation to oxidative stress in epithelial cells. Free Radic Biol Med 38: 1382- 1391
  • Klaver DW, Wilce MC, Cui H, Hung AC, Gasperini R, Foa L, Small DH (2010) Is BACE1 a suitable therapeutic target for the treatment of Alzheimer's disease? Current strategies and future directions. Biol Chem 391: 849- 859
  • May PC, Dean RA, Lowe SL, Martenyi F, Sheehan SM, Boggs LN, Monk SA, Mathes BM, Mergott DJ, Watson BM et al (2011) Robust central reduction of amyloid-beta in humans with an orally available, non-peptidic beta-secretase inhibitor. J Neurosci 31: 16507- 16516
  • Pasternak SH, Callahan JW, Mahuran DJ (2004) The role of the endosomal/lysosomal system in amyloid-beta production and the pathophysiology of Alzheimer's disease: reexamining the spatial paradox from a lysosomal perspective. J Alzheimer Dis 6: 53- 65
  • Qi X, Hauswirth WW, Guy J (2007a) Dual gene therapy with extracellular superoxide dismutase and catalase attenuates experimental optic neuritis. Mol Vis 13: 1- 11
  • Qi X, Sun L, Lewin AS, Hauswirth WW, Guy J (2007b) Long-term suppression of neurodegeneration in chronic experimental optic neuritis: antioxidant gene therapy. Invest Ophthalmol Vis Sci 48: 5360- 5370
  • Rahimi N (2006) VEGFR-1 and VEGFR-2: two non-identical twins with a unique physiognomy. Front Biosci 11: 818- 829
  • Rahimi N, Golde TE, Meyer RD (2009) Identification of ligand-induced proteolytic cleavage and ectodomain shedding of VEGFR-1/FLT1 in leukemic cancer cells. Cancer Res 15: 2607- 2614
  • Rakoczy PE, Baines M, Kennedy CJ, Constable IJ (1996) Correlation between autofluorescent debris accumulation and the presence of partially processed forms of cathepsin D in cultured retinal pigment epithelial cells challenged with rod outer segments. Exp Eye Res 63: 159- 167
  • Sealy JM, Truong AP, Tso L, Probst GD, Aquino J, Hom RK, Jagodzinska BM, Dressen D, Wone DW, Brogley L et al (2009) Design and synthesis of cell potent BACE-1 inhibitors: structure-activity relationship of P1' substituents. Bioorg Med Chem Lett 19: 6386- 6391
  • Sengupta N, Caballero S, Sullivan SM, Chang LJ, Afzal A, Li Calzi S, Kielczewski JL, Prabarakan S, Ellis EA, Moldovan L et al (2009) Regulation of adult hematopoietic stem cells fate for enhanced tissue-specific repair. Mol Ther 17: 1594- 1604
  • Shaw LC, Pan H, Afzal A, Calzi SL, Spoerri PE, Sullivan SM, Grant MB (2006) Proliferating endothelial cell-specific expression of IGF-I receptor ribozyme inhibits retinal neovascularization. Gene Ther 13: 752- 760
  • Solans A, Estivill X, de La Luna S (2000) A new aspartyl protease on 21q22.3, BACE2, is highly similar to Alzheimer's amyloid precursor protein beta-secretase. Cytogenet Cell Genet 89: 177- 184
  • Sparrow JR, Boulton ME (2005) RPE lipofuscin and its role in retinal pathobiology. Exp Eye Res 80: 595- 606
  • Stachel SJ, Coburn CA, Steele TG, Jones KG, Loutzenhiser EF, Gregro AR, Rajapakse HA, Lai MT, Crouthamel MC, Xu M et al (2004) Structure-based design of potent and selective cell-permeable inhibitors of human beta-secretase (BACE-1). J Med Chem 47: 6447- 6450
  • Tombran-Tink J (2005) The neuroprotective and angiogenesis inhibitory serpin, PEDF: new insights into phylogeny, function, and signaling. Front Biosci 10: 2131- 2149
  • Vassar R, Kovacs DM, Yan R, Wong PC (2009) The beta-secretase enzyme BACE in health and Alzheimer's disease: regulation, cell biology, function, and therapeutic potential. J Neurosci 29: 12787- 12794
  • Wassell J, Ellis S, Burke J, Boulton ME (1998) Fluorescence properties of autofluorescent granules generated by cultured human RPE cells. Invest Ophthalmol Vis Sci 39: 1487- 1492
  • Woo HN, Baik SH, Park JS, Gwon AR, Yang S, Yun YK, Jo DG (2011) Secretases as therapeutic targets for Alzheimer's disease. Biochem Biophys Res Commun 404: 10- 15
  • Wu FT, Stefanini MO, Mac Gabhann F, Kontos CD, Annex BH, Popel AS. (2010) A systems biology perspective on sVEGF R1: its biological function, pathogenic role and therapeutic use. J Cell Mol Med 14: 528- 552
  • Xiong K, Cai H, Luo XG, Struble RG, Clough RW, Yan XX (2007) Mitochondrial respiratory inhibition and oxidative stress elevate beta-secretase (BACE1) proteins and activity in vivo in the rat retina. Exp Brain Res 181: 435- 446
  • Yoshida T, Ohno-Matsui K, Ichinose S, Sato T, Iwata N, Saido TC, Hisatomi T, Mochizuki M, Morita I et al (2005) The potential role of amyloid beta in the pathogenesis of age-related macular degeneration. J Clin Invest 115: 2793- 2800